Genmab | GEN - Loan Capital

Stock Price
1,987.50
Daily Change
-19.50 -0.97%
Monthly
-6.07%
Yearly
43.55%
Q1 Forecast
1,920.90

Genmab reported DKK126M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Almirall EUR 386.13M 4.5M Jun/2025
Amgen USD 52.43B 1.33B Sep/2025
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 6.55B 19.43B Sep/2025
Bayer EUR 32.71B 1B Sep/2025
BioMarin Pharmaceutical USD 596.66M 501K Sep/2025
Demant DKK 18.98B 3.71B Dec/2025
Fresenius Medical Care EUR 9.34B 3.01B Sep/2025
Galapagos EUR 5.76M 290K Sep/2025
Genmab DKK 126M 6M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GN Store Nord DKK 8.9B 9M Dec/2025
GRIFOLS EUR 9.09B 1.64B Sep/2025
Hikma Pharmaceutical USD 798M 191M Jun/2025
Insmed USD 539.72M 21.23M Sep/2025
Lonza CHF 4.24B 602M Dec/2024
Merck EUR 10.45B 4.15B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
UCB EUR 2.82B 146M Jun/2025